PGY2 Oncology Pharmacy Residency Program


Residency Program Director
Amber B. Clemmons, Pharm.D., BCOP

Applications and Inquiries:   (Accepting inquiries for 2020-2021 residency year)




Oncology Preceptors

LeeAnn Thompson Lee, Pharm.D., BCPPS; Joshua Wyche, Pharm.D., MBA; Amber Clemmons, Pharm.D., BCOP; Marjorie Shaw Phillips, M.S., R.Ph., CIP; Cara Iacobellis, Pharm.D.; Carolyn Braithwaite, Pharm.D.; Andrea Clarke, Pharm.D.Katie Saunders, Pharm.D. BCOP 

Past Residents

Year Resident Position After Graduation (current)


Katerina (Katsanevas) Butler, PharmD, BCOP Clinical Pharmacy Specialist Hematology/Oncology, AU Medical Center (now at VA in Salt Lake City UT)


Stephen Clark, PharmD, BCOP Clinical Pharmacy Specialist Hematology/Oncology, AU Medical Center (now inpatient at UNC in NC)


Alison (Steinbach) Tokarchic, PharmD Clinical Pharmacy Specialist Hematology/Oncology (outpatient) at Alleghany Health Network in PA


Megan Hartranft, PharmD, BCPS, BCOP Clinical Assistant Professor at Rosalind Franklin University & Ambulatory Care Hematology/Oncology Clinical Pharmacy Specialist at Rush University Medical Center in Chicago, IL. (now MLS with PHARMA)


Sarah (Evans) Hoffman, PharmD, BCOP Clinical Pharmacy Specialist Inpatient/Outpatient Medical Oncology at the Ohio State University Comprehensive Cancer Center in OH


Julianne (Orr) Darling, PharmD, BCOP Oncology Clinical Pharmacist at the Indiana University Health in IN


Benjamin Andrick, PharmD, BCOP Hematology/Oncology Clinical Pharmacist and Clinical Investigator at Geisinger Health in PA


Morgan (Gwynn) Stanley, YeaPharmD, BCOP Oncology Clinical Pharmacist at the University of North Carolina in Chapel Hill, NC
2018-2019 Kori Daniels, PharmD BMT Clinical Pharmacy Specialist at Methodist University Hospital in Memphis, TN


Residency Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both to the provision of patient care or other advance practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialize positions, along with board certification, if available.

This PGY2 residency program provides the resident with advanced clinical training in hematology/oncology and supportive care pharmacotherapy, as well as numerous opportunities for teaching and scholarship. Upon completion of this residency, the pharmacist will be a competent clinical pharmacy practitioner who engages in multidisciplinary collaboration, demonstrates advanced critical thinking skills, and promotes patient advocacy. Graduates of this program will be adequately prepared to
enter oncology pharmacy practice as a clinical specialist and/or academician.